Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n°159

Posts Tagged ‘congress’

International Liver Congress™ 2019

Posted by fidest press agency su sabato, 6 aprile 2019

Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. (hereafter “Shionogi”), announced it will present four posters on lusutrombopag, a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, at The International Liver Congress™, the annual meeting of the European Association for the Study of the Liver (EASL), to be held in Vienna, Austria, April 10-14, 2019. Lusutrombopag was granted marketing authorisation by the European Commission (EC) on February 18, 2019 for the treatment of severe thrombocytopenia in adult patients with chronic liver disease (CLD) undergoing invasive procedures. It has already been approved for use in Japan1 and the US where it is marketed under the brand name Mulpleta®2.All poster presentations will be displayed in Reed Messe Wien Exhibition & Congress Center Hall B on Saturday, April 13, 2019 from 9:00 am to 5:00 pm Central European Time (CET). The research will be presented in the Cirrhosis and Complications poster area and will include the following: Poster SAT 002: Lusutrombopag Is a Safe Treatment Option for Thrombocytopenia in Patients with Chronic Liver Disease Undergoing an Invasive Procedure: Pooled Safety Analysis from 3 Studies.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Mobile World Congress 2019

Posted by fidest press agency su sabato, 23 febbraio 2019

Barcelona 25th of February from 01:00 to 02:30pm. Venue FIBOCOM: Hall 1. Stand 1E21.FIA is built as a collaboration with operators and partners to focus on new innovations and IoT devices born from the advances of 5G connectivity. With a strong background in IoT through support from Fibocom Wireless Inc., Fibocom is the first wireless communication module and solution provider listed publicly in China(SHE: 300638). For over 20 years, Fibocom has been dedicated to providing many global top 500 IoT consumer electronics, and global carrier companies with end-to-end wireless communication solutions covering 5G, LTE, NB-IoT/eMTC, HSPA+, and GSM/ GPRS. This strong background is further enabled by the world’s largest PC parts/CPU manufacturer, and major Fibocom shareholder, Intel.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Intel at Mobile World Congress 2019

Posted by fidest press agency su domenica, 3 febbraio 2019

Barcelona Feb. 25-28 Fira Gran Via, Hall 3, Intel Booth 3E31 At Mobile World Congress 2019, Intel will demonstrate solutions powering the 5G future. Come experience compelling use cases highlighting the power of 5G across client, cloud, network and edge, enabling Intel customers to deliver new innovative capabilities and scalable and efficient business models. As the world moves beyond connecting billions of humans to connecting billions of “things,” Intel’s world-class data-centric technologies and solutions will drive 5G’s usefulness and presence everywhere.
See how delivering 5G’s expanded capacity in a manufacturing setting will enable safer, more flexible and more efficient production by applying machine-to-machine connectivity, transformed networks, computer vision, edge computing and AI capabilities to real-world applications.
Learn how edge computing will enable new revenue-generating, immersive media experiences (virtual reality/augmented reality gaming) for consumers anywhere, without being tethered to a wired network. See how Hollywood is embracing the power of Intel processing and software and the visual cloud to bring its latest films to life.
5G’s gigabit speeds, transformed networks and edge computing augmented by new computer vision and AI technologies will give retailers new capabilities to efficiently enable retail deployments in virtually any location without the expense of a wired infrastructure.
See the latest Intel partner ecosystem offerings in network, edge, vRAN and base station technology – enabled by Intel® Xeon® Scalable processors, Intel® FPGAs, Intel Atom® processors, and Intel connectivity products.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

World Jewish Congress’ 2019

Posted by fidest press agency su lunedì, 7 gennaio 2019

New York, NY – The World Jewish Congress launches today its annual WeRemember campaign, to combat anti-Semitism and all forms of hatred, genocide and xenophobia. The campaign, which runs January 6-27, will take off simultaneously in 50 countries, in 20 languages, with a number of partners including several social media giants and the United Nations Educational, Scientific, and Educational Organization (UNESCO).
The 2019 WeRemember initiative, now in its third year, urges people around the world to photograph themselves holding a #WeRemember sign and post it to social media, to spread the message that never again must mean never again. Last year, the campaign reached more than 650 million people – more than one out of 11 people worldwide.
Participant photos, interviews with Holocaust survivors, and messages from influencers of varied backgrounds, professions, ages and religions will be projected on the walls of Auschwitz-Birkenau and live streamed from January 24-27. The campaign is being held in advance of International Holocaust Remembrance Day on January 27, the anniversary of the liberation of the Auschwitz-Birkenau Nazi death camp in 1945.Social media companies, including Twitter and Snapchat, will support the World Jewish Congress’ campaign in various ways. On Snapchat, for example, the Our Story coverage of the day, including content related to Holocaust education, will be available on the Discover page on 27 January 27. Snapchatters can join the conversation by submitting their Snaps to the public Our Story using the available Filters.
The United Nations Educational, Scientific, and Cultural Organization (UNESCO) has also joined the WJC as an integral partner, after launching together a joint website on Holocaust education (aboutholocaust.org). Roberta Grossman and Nancy Spielberg, the filmmakers of Who Will Write Our History, and their distributor Abramorama, are supporting the We Remember project during the global event screening in over 200 venues around the globe.The campaign will launch with a unique call by a number of Holocaust survivors who have a mission to educate the world to create a better future, and to share their stories with younger generations. These survivors include, inter alia, Toby Levy, a social media activist who has dedicated her life to educating the next generation about the danger of hatred, and Saul Dreier, the founder of the Holocaust Survivor Band and an advocate for using music as a form of remembrance. Participants amplifying the 2019 initiative also include reformed neo-Nazis, sports teams and association and people of all religions and backgrounds.
Previous campaign participants include: Pope Francis, United Nations Secretary General António Guterres, First Lady Melania Trump, Prime Minister of Israel Benjamin Netanyahu, Prime Minister of Belgium Charles Michel, Former U.S. Ambassador to the United Nations Nikki Haley, Senator of New York Charles Schumer, actress Gal Gadot, Foreign Minister of Russia Sergey Lavrov, Former Minister for Foreign Affairs of Germany Sigmar Gabriel, Holocaust survivors, and supporters from all walks of life fighting rampant antisemitism.

Posted in Estero/world news, Spazio aperto/open space | Contrassegnato da tag: , | Leave a Comment »

EOS imaging to Present Its EOSapps Suite at the French Society of Orthopedic and Traumatological Surgery Congress

Posted by fidest press agency su giovedì, 15 novembre 2018

EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI – Eligible PEA – PME), a pioneer in 2D/3D orthopedic medical imaging, will present its EOSapps solution with particular focus on hipEOS 3.0 online surgical planning software at the French Society of Orthopedic and Traumatological Surgery (SOFCOT) Congress, being held November 12-15, 2018 at the Palais des Congrès in Paris.The congress program will include the symposium: “Planning, Executing, Evaluating the Total Hip Arthproplasty: EOS Solutions at Each Step of the Care Pathway” on Wednesday, November 14th at 12:30 pm in Room 343, with Professor Jean Yves Lazennec (AP-HP, Paris) and Doctor Nicolas Verdier (Clinique Jean Villar, Bordeaux). Prof. Lazennec address will focus on current progresses in total hip arthroplasty (THA) made possible by post-operative analysis with the EOS solution. Dr. Verdier will share first time results about the association of hipEOS 3D surgical planning with intra-operative navigation (Orthopilot – BBraun) to execute a 3D, personalized plan for patient hip replacement that takes into account the patient anatomy in the weight-bearing and seated functional positions. The anatomical and functional information provided by hipEOS was used in real time in the operating room to guide navigation and achieve optimal positioning of the implant components.”We are pleased to see presentations at SOFCOT of further progress in hip prosthesis surgery thanks to our 3D imaging and online automated surgical simulation solution. EOS planning, combined with navigation – as well as other per-operative execution systems such as robotics – makes it possible to consider more precise surgeries with better clinical results. We are very proud to be able to offer new perspectives to surgeons and patients to improve the management of THA, a high volume and costly procedure” concluded Marie Meynadier, Chief Executive Officer of EOS imaging.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Cabozantinib to Be Featured in 13 Presentations at ESMO 2018 Congress

Posted by fidest press agency su giovedì, 11 ottobre 2018

Exelixis, Inc. (NASDAQ:EXEL) announced that data from clinical trials of cabozantinib will be the subject of 13 presentations at the European Society for Medical Oncology (ESMO) 2018 Congress, which is being held October 19-23, 2018 in Munich, Germany.Poster presentations will include results from the dose escalation stage of the phase 1b COSMIC-021 study of cabozantinib in combination with atezolizumab in previously untreated advanced renal cell carcinoma (RCC). Additionally, a poster discussion session will feature a late-breaking abstract evaluating the effect of PD-L1 status on clinical outcomes with cabozantinib in advanced RCC in the CABOSUN and METEOR trials.“The data at ESMO showcase the potential of cabozantinib across a range of difficult-to-treat cancers,” said Gisela Schwab, M.D., President, Product Development and Medical Affairs and Chief Medical Officer, Exelixis. “We are especially excited to present results from the dose escalation stage of the COSMIC-021 trial evaluating the combination of cabozantinib and atezolizumab in advanced kidney cancer and look forward to sharing these data and more with the oncology community at this year’s ESMO Congress.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

HeartSciences Showcases MyoVista® Wavelet ECG at 2018 European Society of Cardiology Congress

Posted by fidest press agency su venerdì, 24 agosto 2018

HeartSciences, a medical device company developing next generation ECG devices using continuous wavelet transform (CWT) signal processing and artificial intelligence, is proud to announce its participation as an exhibitor at the upcoming 2018 European Society of Cardiology Congress (ESC). The Congress will take place at Messe Munich International in Munich, Germany and will run from August 25 to August 29, 2018. HeartSciences will highlight its MyoVista® Wavelet ECG (wavECG™) Cardiac Testing Device as well as recent clinical study results published in the Journal of the American College of Cardiology (JACC)
HeartSciences is advancing the field of electrocardiography through the application of wavelet signal processing and artificial intelligence to develop next generation ECG technology. Wavelet signal processing is currently used in many different industries as an important tool to provide insights and new valuable data related to spectral analysis of a signal. HeartSciences’ MyoVista wavECG Cardiac Testing Device is a 12-lead resting electrocardiograph utilizing continuous wavelet transform (CWT) based signal processing. Patented informatics focus on energy related information rather than conventional voltage-based information. HeartSciences mission is to enable accurate, affordable screening for the early detection of heart disease.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

The 24th World Congress of Philosophy began on August 13 at the Great Hall of the People in Beijing

Posted by fidest press agency su martedì, 14 agosto 2018

The conclave of thought meets under the motto “Learning to be Human” and will take place throughout the week, to be closed on the 20th.The planned panels promise a very long journey through different systems of thought, deepening with special relevance into the philosophical disciplines of the East, but also giving rise to new proposals.Among these, Vito Correddu, a researcher at the Salvatore Puledda Centre of Humanist Studies in Rome, will be present on behalf of the World Centre for Humanist Studies. He will speak about “The Revolution as a way to be completely human” on Friday 17 February.Together with him, Mehdi Parsakhanqah (Allameh Tabataba’i University, Tehran), Anastasiya Kriman (Lomonosov State University, Moscow), Mirko Garasic (UNESCO Chair in Bioethics and Human Rights, Rome) and Youngmin Kim (Dongguk University, Seoul) will be presenting at the “Humanism and Post-Humanism” table, moderated by Sigridur Thorgeirsdottir from the University of Iceland.The programme includes hundreds of presentations, round tables, master classes and plenary sessions, which will undoubtedly bring together not only the best intuitions and analyses of past times, but will also attempt to resolve in a harmonious synthesis questions of the present and perspectives of human life in the future. (by Pressenza international press agency About The Author Centro Mundial de Estudios Humanistas)

Posted in Estero/world news, Università/University | Contrassegnato da tag: , , | Leave a Comment »

BIO Wraps up Transformative 2018 BIO World Congress in Philadelphia

Posted by fidest press agency su domenica, 22 luglio 2018

The 15th annual BIO World Congress on Industrial Biotechnology concluded today at the Pennsylvania Convention Center in Philadelphia. The BIO World Congress continues to be the largest industrial biotechnology conference in the world, and this year’s event had a significant international presence with 44 percent of attendees coming from outside the United States. Additionally, more than 100 new companies were in attendance in Philadelphia.
Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, said, “Like previous years, the 2018 BIO World Congress featured robust programming for anyone working in industrial biotechnology. From intriguing plenary and breakout sessions to investment and partnering opportunities, this event provides industry executives, investors, policy makers and academics the best opportunity to collaborate to strengthen the biobased economy.”The three days of BIO World Congress programming included over 70 programming sessions, featuring 28 breakout sessions across seven tracks, more than 20 poster presentations, 10 GreenTech Investor Sessions and four sponsored workshops. The conference also offered a new efficient element of the program featuring 60 company and technical presentations.
The conference also hosted large delegations from Australia, Thailand and Uruguay. The delegation from Queensland, Australia was led by the Minister for State Development, Manufacturing, Infrastructure and Planning, the Honourable Cameron Dick.BIO One-on-One PartneringTM sponsored by Iowa, State of continued to be a key value driver with nearly 2,000 partnering meetings taking place over the three days.BIO and sponsor IowaBio presented the 2018 George Washington Carver Award for Innovation in Industrial Biotechnology and Agriculture to Dr. Sang Yup Lee, Korea Advanced Institute of Science and Technology (KAIST). The annual award was established by BIO more than a decade ago to recognize significant contributions by individuals in the field of industrial biotechnology and its application in biological engineering, environmental science, biorefining, and biobased products.BIO and sponsor The Rosalind Franklin Society presented the 2018 Rosalind Franklin Award for Leadership in Industrial Biotechnology and Agriculture to Krysta Harden, vice president of external affairs and chief sustainability officer at Corteva AgriscienceTM. The award is presented to an outstanding woman in the industrial biotechnology sector who has made significant contributions to the advancement of the biobased economy and biotech innovation. Harden is the fifth recipient of the annual award.
BIO also honored Dr. Larry Walker, Industrial Biotechnology Journal, with its third annual BIO Leadership and Legacy Award in Industrial Biotechnology and Agriculture.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Veracyte Announces Launch of New Afirma Xpression Atlas at 2018 AACE Congress

Posted by fidest press agency su lunedì, 21 maggio 2018

Veracyte, Inc. (Nasdaq: VCYT) today announced the launch of the new Afirma Xpression Atlas, an RNA sequencing-based test that provides extensive genomic information to aid in surgery and treatment decisions for patients with potentially cancerous thyroid nodules. The new test is being introduced at the AACE 27th Annual Scientific & Clinical Congress where robust test performance data will be shared in a Product Theater event and poster presentation by Veracyte and external researchers. The AACE meeting is being held May 16-20 in Boston.
The Afirma Xpression Atlas detects 761 DNA variants and 130 RNA fusion pairs in over 500 genes that have been linked to thyroid cancer. In some cases, these gene alterations have demonstrated association with more aggressive thyroid cancers or with higher-stage disease.
“For patients who are already going to surgery for suspected thyroid cancer, the Afirma Xpression Atlas provides additional genomic information that physicians and patients may use in decisions about the surgical approach,” said Peter M. Sadow, M.D., Ph.D., of Massachusetts General Hospital and Harvard Medical School. “Additionally, as more is understood about gene alterations and their impact on thyroid cancer development, prognosis and tumor pathway dependence, this RNA sequencing information may help to further guide patient care.” Dr. Sadow will present performance data for the Xpression Atlas test during a poster session at the AACE meeting on Saturday, May 19. The gene variants and fusion partners in the Afirma Xpression Atlas were derived from the thyroid literature and from The Cancer Genome Atlas (TCGA). The RNA-sequencing based panel is offered as an extension to Veracyte’s market-leading Afirma Genomic Sequencing Classifier (GSC), which is widely used to identify benign nodules among those deemed indeterminate by cytopathology so that patients can avoid unnecessary surgery.“In tandem with our Afirma GSC, the Afirma Xpression Atlas provides physicians with the most comprehensive and evidence-based genomic information available to inform diagnosis, stratify thyroid cancer risk and, for those who are diagnosed with cancer, aid in therapeutic selection,” said Bonnie Anderson, Veracyte’s chairman and chief executive office.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

World Jewish Congress presents Israeli President Reuven Rivlin

Posted by fidest press agency su venerdì, 20 aprile 2018

'Declaration of the Jewish Diaspora_sJERUSALEM – The World Jewish Congress (WJC) on Tuesday hand-delivered to Israeli President Reuven Rivlin its official “Declaration of the Jewish Diaspora’s Commitment to the State of Israel on the Occasion of the 70th Anniversary of the Establishment of the State of Israel,” signed by the leaders of 83 Jewish communities around the world and members of the WJC Steering Committee.
The World Jewish Congress initiated and adopted this unprecedented declaration on behalf of its affiliated communities on six continents, as a manifesto of Diaspora Jewry’s “immense pride and admiration for Israel’s remarkable and inspiring achievements over the course of the past seven decades” and as a pledge of its “steadfast and unwavering support for Israel as the nation state of the Jewish people and its centrality to the Jewish people.”
World Jewish Congress President Ronald S. Lauder said: “The World Jewish Congress, representing 100 Jewish communities on six continents, is deeply committed to the State of Israel and its citizens. This manifesto is a declaration of our promise to continue to defend and promote the Jewish state, and to stand by and assist in ensuring its bright and secure future”. The declaration, designed in the format of Israel’s original Declaration of Independence, was delivered to Israeli President Reuven Rivlin by a World Jewish Congress delegation led by WJC CEO Robert Singer and representatives of the WJC’s flagship program, the WJC-Jewish Diplomatic Corps – the future leaders of Jewish communities worldwide. Upon accepting the declaration, Israeli President Reuven Rivlin said: “At the root of our relationship as the Jewish people there is one simple, absolute understanding that must prevail: our mutual responsibility for one another; our commitment to the security, liberty, and welfare of every member of our people. This commitment must be stronger than any disagreement. We have the challenge of cementing the ties between us as a value that stands beyond any debate. Our relationship must always stand at the heart of Jewish existence, a mission that is part of the State of Israel’s commitment to the Jewish people. I am pleased to accept this moving declaration, a simple proof of this mutual responsibility that we must never forgo.”
The full Declaration will be issued to the public on Wednesday, the eve of Israel’s 70th Independence Day.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Arista Demonstrates Cloud-Grade Routing at MPLS + SDN + NFV World Congress 2018

Posted by fidest press agency su venerdì, 13 aprile 2018

Arista Networks (NYSE:ANET) today announced that the European Advanced Networking Test Center (EANTC) has successfully verified the interoperability of key Arista EOS® (Extensible Operating System) routing capabilities at the MPLS + SDN + NFV World Congress 2018 interoperability showcase. Arista participated in several interoperability tests designed and exercised by EANTC targeting Ethernet VPN (EVPN) technology for VxLAN and MPLS and MPLS Segment Routing (ISIS and BGP), spanning use cases across datacenter, Wide Area Network (WAN) and Core network deployments.
Carsten Rossenhoevel, Co-founder and Managing Director of EANTC, said, “In just the second year that Arista has been part of our public interoperability event, Arista has displayed EVPN, MPLS, Segment Routing capabilities comprehensively with impressive results. We look forward to continuing to work with Arista to promote industry standards-based interoperable solutions.”
By participating in EANTC multi-vendor tests, targeting modern technologies for IP, MPLS, and VxLAN networks, Arista Networks is ensuring its continued commitment to open standards. Customers can leverage Arista EOS routing capabilities along with EOS automation, programmability and rich telemetry to accelerate the transition to Cloud-Grade Routing.“At BIT we are passionate about technology and delivering the best quality of service to our customers. We chose Arista EVPN for our infrastructure because it allows us to scale our datacenter network to current and future needs,” said Teun Vink, Network Manager at BIT B BIT uses EVPN to deliver a scalable network that is 100% loop free, optimally uses the available links and continues to support all the traditional protocols (e.g. STP). In addition, the strengths of integration with Open Source tooling in EOS, with unmodified Linux on the switch, full support of DevOps, streaming telemetry and API’s for tooling to leverage were a huge plus for the deployment.A whitepaper detailing all the tests and results can be obtained from EANTC at http://www.eantc.de/showcases/. Arista will be demonstrating all of these routing technologies along with Arista cloud solutions such as CloudVision® for Automation, Analytics, Agility with OpenConfig / NETCONF and Any Cloud Platform at the MPLS+SDN+NFV World Congress 2018 in Paris from April 10th through 13th, 2018 (Booth #210).www.arista.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Basic cardiovascular science congress set to stimulate public discussion on genome editing

Posted by fidest press agency su martedì, 27 marzo 2018

Vienna, Austria 20 to 22 April. The European Society of Cardiology’s (ESC) basic science congress is set to stimulate public discussion on the use of genome editing and other cutting edge technologies to prevent cardiovascular disease.Frontiers in CardioVascular Biology (FCVB) 2018 is organised by the Council on Basic Cardiovascular Science of the ESC in collaboration with 12 European cardiovascular science societies. It will be held from 20 to 22 April at the Austria Centre Vienna. The full scientific programme is available here.Germline genome editing, which is performed in either the oocyte or sperm, could be used to prevent disease – for example hypertrophic cardiomyopathy, which is caused by a mutation in the MYBPC3 gene. It could also be used to reduce the risk of coronary heart disease by, for example, introducing a loss-of-function in the PCSK9 gene, thereby interfering with cholesterol levels. Another application could be to introduce advantageous or otherwise desirable traits such as athletic ability.Tissue engineering will also be explored at the congress. The technique could be used in patients with end-stage heart failure by growing a patch of healthy cells outside the body and then implanting it into the damaged area of the heart to support its pump function.Experts will present the latest data linking gut bacteria and their metabolites with health and disease. Certain combinations have been associated with atherosclerosis, hypertension, type 2 diabetes, and heart failure.
Leaders in the field of cell therapy, in which stem cells or progenitor cells are injected into the patient to repair a damaged heart, will explore the pros and cons of this technique and discuss why meta-analyses of randomised trials assessing cell therapy to promote cardiac repair in myocardial infarction have reported conflicting results.Professor Wojta said: “Another issue is that the results of cell therapy have been promising in animal models but modest in humans. One explanation is that we have used young, healthy animals with artificially induced myocardial infarction whereas patients are older, unhealthy, and have developed coronary heart disease over years or decades until experiencing a myocardial infarction.”He concluded: “Cell therapy is an area of research in which we moved very quickly from the bench to the bedside. We need to go back to the bench and come up with more relevant animal models that could give us better solutions for use in humans.”

Posted in Medicina/Medicine/Health/Science | Contrassegnato da tag: , , | Leave a Comment »

The Russian Export Center Will Be Presenting Innovative Russian Solutions at the Mobile World Congress in Barcelona for the First Time

Posted by fidest press agency su giovedì, 22 febbraio 2018

The Russian Export Center will be introducing home-grown, Russian technology at the 2018 Mobile World Congress (MWC) in Barcelona for the first time. Seventeen Russian companies will showcase their unique, powerful and competitive solutions to a world audience from February 26th to March 1st, from the Russian Booth (Pavilion No. 6, booth 6H20 and 6I11).A special business program is organized for the Russian booth, to create opportunities for Russian companies to enter the international market and non-Russian companies to promote their business in Russia.We would like to welcome media and attendees to special events at the Russian Export Center exposition including:
– A special session with the leading Russian newspaper “Kommersant”, titled “New business opportunities in the digital age” involving Russian and foreign experts (February 26).
– A Russian Business Communication Day: the official opening of the Russian booth, a series of “elevator pitches”, interviews with the leaders of participating companies, a cocktail party and B2B meetings (February 27).
For more information and for accreditation to the Russian booth events, please contact the Press Center of the Russian exposition operator INCONNECT Group.
JSC Russian Export Center (REC) — State Institute for Export Support, established with the support of the Government of the Russian Federation. The Center represents a “single window” (one-stop solution) for working with exporters in the field of financial and non-financial support measures, including cooperation with relevant ministries and agencies. To form a “one-stop solution” concept, the Export Insurance Agency of Russia (JSC EXIAR) and JSC ROSEXIMBANK were integrated into the Russian Export Center group. In the ordinary course of activities, REC provides a wide range of services to producers of non-resource products at all stages of export cycle, interacts with the relevant executive authorities, prepares proposals for improving the business environment in terms of exports and foreign trade, cooperates regularly with representatives of business and expert community, contributes to overcoming the barriers and removal of “systemic” restrictions. The detailed information is on website of the Russian Export Center: http://exportcenter.ru

Posted in Economia/Economy/finance/business/technology | Contrassegnato da tag: , , | Leave a Comment »

New ESC guidelines on syncope and latest science to be released at EHRA 2018 congress

Posted by fidest press agency su giovedì, 15 febbraio 2018

Barcelona, Spain 18 to 20 March 2018. New European Society of Cardiology Clinical Practice Guidelines on syncope will be presented and published online for the first time during EHRA 2018, which will be held 18 to 20 March in Barcelona, Spain.Formerly the EHRA Europace congress held annually in June, EHRA 2018 marks the beginning of a new schedule, in which the congress will be held in March each year. It is the annual congress of the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC). EHRA’s aim is to improve quality of life by reducing the impact of cardiac rhythm disturbances and reducing sudden cardiac death. The yearly congress is an important activity towards meeting this aim; it covers the full spectrum of arrhythmias management, from atrial fibrillation to stroke, and from simple to complex arrhythmias. It will be held from 18 to 20 March in Barcelona, Spain, at the Fira Gran Via. The full scientific programme is available here.A record number of late-breaking science abstracts were submitted for the congress this year.2 Highlights to be presented include the AXAFA-AFNET trial on the impact of continuous apixaban during catheter ablation; the MORE-CRT MPP trial on the benefits of cardiac resynchronisation therapy (CRT) with multipoint pacing; two studies on the outcome of surgical versus catheter ablation in atrial fibrillation; and new data from the BRUISE CONTROL-1 and 2 trials on continued versus interrupted non-vitamin K antagonist oral anticoagulants (NOACs) during device implantation.Innovative technologies will be presented in a special session that will focus on the accuracy of smartphone applications for detecting atrial fibrillation; the effectiveness of a novel endovascular balloon for treating vein tears during transvenous lead extraction; and the benefit of ultra-low temperatures for cryoablation of atrial fibrillation.Registries provide real life data and late-breaking findings will be presented in a dedicated session. Two-year follow-up results with the WATCHMAN left atrial appendage closure device will reveal the impact on stroke and bleeding; two-year outcomes will also be presented from the GLORIA-AF registry on dabigatran use in almost 5,000 patients with atrial fibrillation; and the ALTITUDE registry of more than 145,000 patients will give insights into how device programming can reduce unnecessary implantable cardioverter defibrillator (ICD) shocks.
EHRA will launch a scientific document on arrhythmias and cognitive function, and a practical guide on the use of NOACs in atrial fibrillation.An entire session is devoted to the novel use of magnetic resonance imaging (MRI) to guide ablation of atrial fibrillation. International experts will present cutting edge data, giving a complete picture on whether real-time MRI guidance can improve ablation outcomes.Controversial issues will be debated by world opinion leaders on issues such as whether a subcutaneous ICD should be preferred over a transvenous ICD to prevent sudden death, and whether anticoagulation can be stopped after successful catheter ablation of atrial fibrillation.
Summits will be held on e-health, cardiac mapping, lead and device management, and ventricular tachycardia. Members of the press can watch state-of-the-art techniques being performed in live sessions streamed from Barcelona and Leipzig on atrial fibrillation ablation, pacing, lead extraction, ventricular tachycardia, and MRI-guided procedures.The Einthoven Lecture will be given by Professor Josep Brugada of the University of Barcelona. Professor Jonathan M. Kalman of the University of Melbourne will deliver the Intercontinental Lecture. Professor Helmut Puererfellner, scientific programme vice-chairperson, said: “This is the congress on cardiac arrhythmias, with updates on the entire armamentarium. Save the date now and be among the first to hear the latest scientific findings in this fast-moving field.”

Posted in Estero/world news, Medicina/Medicine/Health/Science | Contrassegnato da tag: , , | Leave a Comment »

Innovations to prevent heart disease take centre stage at EuroPrevent congress

Posted by fidest press agency su mercoledì, 8 marzo 2017

Sophia AntipolisSophia Antipolis. Innovations to prevent heart disease will take centre stage at EuroPrevent 2017 in Malaga, Spain.EuroPrevent is the annual congress of the European Association of Preventive Cardiology (EAPC), a registered branch of the European Society of Cardiology (ESC). EuroPrevent 2017 takes place 6 to 8 April at the Palacio de Ferias y Congresos de Malaga (FYCMA). This year’s theme is “innovations in preventive cardiology”. The congress will explore novel ideas and technologies that could have an impact on society and what that impact could mean. “It’s the right time to talk about innovation in preventive cardiology because we are moving beyond classical treatments and approaches on a number of fronts,” said Professor Jean-Paul Schmid, programme committee chair.
Could the Nordic diet be the new Mediterranean diet? Experts will discuss how it provides cardiovascular protection that is also eco-friendly. Sessions on nutrition will also explore diet and the microbiome as the next frontier in cardiovascular prevention, examine whether patients with metabolic syndrome should eat low carbohydrate or low cholesterol diets, and ask “Do superfoods exist and do we need them?”.“Nutrition used to be our main weapon to lower cholesterol but it took a back seat when statins came on the scene,” said Professor Schmid. “EuroPrevent will look at new therapeutic uses of food and nutrients and also the potential dangers of genetically modified food.”
A breakthrough in the management of high cholesterol could see some patients using monoclonal antibodies called PCSK9-inhibitors. Journalists will find out which patients should add these to their statin regime and how effective the newer drugs are. Novel oral antidiabetic drugs are another important discovery that will be presented.Professor Schmid said: “Monoclonal antibodies are used in oncology and rheumatology, and now intensive lipid lowering with this new class of drugs is a hot topic. This potent medication may help patients unable to reach cholesterol targets on statins alone and better protect patients with familial hypercholesterolaemia who have genetically high cholesterol. Leaders in the field will talk about the safety of very low lipid levels.”
A session on social inequalities will examine cardiovascular disease incidence and survival in migrants, and explain the association between cardiovascular risk factors and borough socioeconomic level. “Cardiovascular disease in migrants is an increasingly important topic and we need strategies for prevention,” said Professor Schmid. “Members of the press will hear about the scale of the problem, how these populations are unique, and how we might screen and then help them.”
The latest science on the health effects of e-cigarettes and waterpipe will be presented, along with the impact of TV and movies on tobacco use and cessation in the young. “After the harms of secondhand smoke were confirmed and actions taken to prevent it we thought we knew everything about tobacco,” said Professor Schmid. “But e-cigarettes have reactivated the discussion about smoking, smoking cessation, and smoking behaviour. We will delve into the latest facts about the hazards of e-cigarettes and waterpipe.”
Experts will present the most up-to-date evidence on physical activity monitoring in patients with cardiovascular disease and investigate whether mobile apps help prevent cardiovascular disease in people of all ages. Journalists will hear lively, balanced debates on whether too much exercise can be detrimental to cardiovascular health, and whether exercise restriction is necessary for athletes with cardiac disease.Dr Michael Joner, previous winner of an ESC Grant for Medical Research Innovation will give the EuroPrevent 2017 Keynote Lecture. The Spanish Society of Cardiology will hold cardiopulmonary resuscitation workshops for the general public at Malaga Town Hall on all three days of the congress.Professor Schmid said: “As the leading international congress in preventive cardiology, EuroPrevent covers epidemiology and population science, cardiac rehabilitation and exercise, and sports cardiology. We are expecting more than 1000 cardiologists, allied health professionals, general practitioners, researchers and policy makers to attend. Journalists should register now for this top notch event.”

Posted in Cronaca/News, Medicina/Medicine/Health/Science | Contrassegnato da tag: , , , | Leave a Comment »

“Changing the Face of Modern Medicine”

Posted by fidest press agency su giovedì, 6 ottobre 2016

laserflorenceFlorence (Italy) 18-21 October Tuesday, October 18th 2016, 12.30 am Press Room (Caravaggio), Ground Floor Fiera Congress Center, Piazza Adua, 1 press conference. The meeting will introduce the most relevant news and topics of the Congress. Speakers names will be confirmed.
A light lunch will be offered after the press conference at 1.30 pm. The working language will be English. Leading researchers, scientists and Key Opinion Leaders from around the world will share and present the latest developments in the field of stem cell research and gene editing and therapies, discussing new understandings of diseases and therapeutic applications to face great healthcare challenges such as Cancer, Haemophilia, Neural, Skeletal, Cardiovascular, Ocular and Alzheimer’s diseases. Promoted by the European Society of Gene & Cell Therapy (ESGCT) and the International Society for Stem Cell Research (ISSCR), in collaboration with the Associazione di Biologia Cellulare e del Differenziamento (ABCD), the Congress is a landmark scientific event, as – for the first time in history – gene therapy has become available to patients as a Standard Marketed Therapy approved by Agencies and Institutions at international level.
Il congresso sarà l’occasione per ospitare interventi di ricercatori e massimi esperti a livello nazionale e internazionale, che faranno il punto su tutte le principali novità nel settore:
– studi e casi clinici
– farmaci in sviluppo
– frontiere e orizzonti che si configurano in aree terapeutiche importanti e che rappresentano le grandi sfide sanitarie dei prossimi anni, come Alzheimer, Cancro, patologie Cardiovascolari
– implicazioni etiche della ricerca
– modelli innovativi di business e collaborazioni pubblico-privato, ruolo dello start-up, numeri e investimenti

Posted in Cronaca/News, Medicina/Medicine/Health/Science | Contrassegnato da tag: , , | Leave a Comment »

Pope Francis at ESC Congress 2016

Posted by fidest press agency su giovedì, 1 settembre 2016

pope francisRome. His Holiness Pope Francis honoured the European Society of Cardiology (ESC) with an historic visit to ESC Congress 2016, the world’s largest scientific summit on cardiovascular medicine. “You look after the heart,” His Holiness told the cardiologists. “How much symbolism is enshrined in this word! How many hopes are contained in this human organ! In your hands you hold the beating core of the human body, and as such your responsibility is very great!”Pope Francis added: “The Magisterium of the Church has always affirmed the importance of scientific research for human life and health. The Church not only accompanies you along this demanding path, but also promotes your cause and wishes to support you.”ESC President, Professor Fausto Pinto, in introducing the Pontiff, said: “The European Society of Cardiology, like the Vatican, is committed to alleviating suffering and promoting healthy lifestyles. Both share a common purpose of delivering care to those in need and helping people live more productive lives.” The European Society of Cardiology brings together healthcare professionals from more than 150 countries to push the boundaries of cardiovascular medicine. ESC Congress, held annually at the end of August, presents more than 6,000 scientific abstracts, identifying the latest discoveries and breakthroughs in the field of cardiology. This year’s congress attracted a record 33,000 cardiology professionals.“There is so much more that could be done, that must be done,” Professor Pinto said to Pope Francis. “In Europe alone, 1.4 million people under the age of 75 die prematurely each year from heart attacks and strokes because, in many cases, they are not getting the timely and effective healthcare they need. “Governments, public health systems, clinics, hospitals, universities, we must all recognise the urgency of this public health crisis. And a crisis is exactly what it is, and how it should be seen.”

Posted in Medicina/Medicine/Health/Science, Roma/about Rome, Spazio aperto/open space | Contrassegnato da tag: , , | Leave a Comment »

ESC Congress 2016 Hot Line tips

Posted by fidest press agency su giovedì, 18 agosto 2016

la sapienza romaRome. ESC Congress 2016 will be held 27 to 31 August in Rome, Italy Get ready for the most highly anticipated cardiovascular science of the year in the ESC Congress 2016 hot lines. The primary results of 30 novel clinical trials will be presented, with findings revealed in advance to the media in six dedicated press conferences. Be the first to hear the results of REVERSE II, a multi-national validation of a clinical decision rule to identify low risk unprovoked venous thromboembolism patients who can discontinue anticoagulants.Find out whether direct or selective catheterisation guided by coronary computed tomography (CT) is the preferred choice in patients with stable suspected coronary artery disease from the findings of the randomised CONSERVE trial.Also in the area of imaging, discover the outcome of the first head-to-head comparison of coronary CT angiography, myocardial perfusion SPECT, PET, and hybrid imaging for diagnosis of ischaemic heart disease in the PACIFIC trial. And get the answer to the question “Does Optical Coherence Tomography Optimise Results of Stenting?” in the randomised DOCTORS trial.Exciting new science will be presented in the field of coronary stenting. ANTARCTIC will demonstrate whether platelet monitoring for dose adjustment of antiplatelet drugs is superior to a conventional fixed dose in elderly patients stented for an acute coronary syndrome. The results of a randomised comparison of ticagrelor and prasugrel in ST-segment elevation myocardial infarction will be unveiled in PRAGUE -18.Don’t miss the randomised phase III trial results from ESCAPE on the effect of alirocumab on the frequency of lipoprotein apheresis, which removes low density lipoprotein (LDL) cholesterol from the blood.Journalists will learn the latest prevention strategies in sleep apnoea (SAVE trial), and resistant hypertension, where outcomes with the novel median nerve modulation technique will be presented. Methods for cardiac rehabilitation have been compared in a randomised, controlled superiority trial of an educational and behavioral intervention and the results from OPTICARE will be released for the first time.Innovative approaches for the treatment of heart failure will be divulged in DANISH, a randomised, controlled trial which examined the effect of an implantable cardioverter defibrillator on mortality in patients with non-ischaemic systolic heart failure. This is just a small taste of the groundbreaking research that will be presented in this year’s hot lines. Additional late breaking science will presented in 25 clinical trial updates, 24 registries and 12 basic and translational hot lines presentations.

Posted in Cronaca/News, Medicina/Medicine/Health/Science, Roma/about Rome | Contrassegnato da tag: , | Leave a Comment »

80th anniversary of the establishment of the World Jewish Congress

Posted by fidest press agency su venerdì, 5 agosto 2016

NEW YORK – As the World Jewish Congress prepared to mark its 80th anniversary, President Ronald S. Lauder declared that vigilance and bold steps were as necessary today as they were in 1936 to defend Jews and Jewish community life, adding that the very existence of the WJC, the international Jewish umbrella organization, keep the situation for Jews around the world from deteriorating to the level of pre-Holocaust Germany. Ronald S. Lauder said:“In 1936, our founding fathers and mothers gathered in Switzerland to unite against the growing threat of Nazi Germany and to bring the Jewish plight to the world’s attention. Today, the world’s attitude toward Jews may still be hostile, but two things have certainly changed. Firstly, we have changed. The era of the quiet Jew, the timid Jew, the Ghetto Jew, is long over. Those leaders who set up the WJC 80 years ago buried that Jew – and he’s not coming back.“Secondly, there is the State of Israel, the only Jewish state in the world. The World Jewish Congress works to defend Israel and its people in the international arena, and we hope to contribute to achieving peace and stability in the Middle East “The founding of the World Jewish Congress put Jewish interests on the map of international diplomacy for the first time. I am sure that the founding fathers and mothers of the WJC, who could not prevent the Holocaust but who did much to help Jews during and after World War II, would have been proud of what the WJC and what Israel have achieved in recent decades.“Much needs to be done to fight anti-Semitism and other forms of bigotry, but as we look back over the last 80 years, it is clear that the world would be an even more dangerous place for Jews were in not for the establishment of the WJC as the representative voice and diplomatic arm of world Jewry.”
8-15 August 1936: Founding assembly of the World Jewish Congress in Geneva The World Jewish Congress was formally established in Geneva, Switzerland, by a plenary assembly of 230 elected representatives from Jewish communities in 32 countries to serve as an umbrella body tasked to defend Jewish rights vis-à-vis governments and international bodies and to mobilize for the establishment of a Jewish home in what was then the Mandate of Palestine.Today, the WJC has affiliated member organizations in over 100 countries and territories and remains the only truly global Jewish umbrella organization.
8 August 1942: Riegner Telegram alerts world to Holocaust During World War II, the WJC set up a relief body to assist persecuted Jews in Europe and it alerted the world to the Holocaust. On 8 August 1942, the WJC’s Geneva representative Gerhart Riegner sent the famous telegram in which he informed the United States for the first time about the Nazis’ ‘Final Solution of the Jewish Question’, the plan to exterminate all Jews in the German-occupied territories. Riegner had received his information from the German industrialist Eduard Schulte.Throughout the war, the WJC lobbied the Allied governments to grant entry visas to Jewish refugees. Despite the US State Department’s opposition, the WJC obtained permission from the US Treasury Department, headed by Henry Morgenthau, to transmit funds to Europe for the rescue and assistance of persecuted Jews. According to a report by Riegner, these funds helped to bring 1,350 Jewish children from the occupied countries to Switzerland and 70 to Spain.
First Plenary AssemblyOn 9 August 1944, the head of the WJC’s Rescue Department, Arieh Leon Kubowitzki, sent a letter to the US Undersecretary of War John McCloy, relaying a message from Ernest Frischer of the Czechoslovak State Council urging the destruction of gas chambers and crematoria in Auschwitz-Birkenau and the bombing of railway communications in this area.
On 14 August 1944, McCloy replied to Kubowitzki by rejecting the idea, saying that “such an operation could be executed only by the diversion of considerable air support essential to the success of our forces now engaged in decisive operations elsewhere and would in any case be of such doubtful efficacy that it would not warrant the use of our resources.”In April 1945, the WJC managed to obtain the liberation of 4,500 inmates from the women’s concentration camp Ravensbrück through direct negotiations with top Nazi leader Heinrich Himmler.
In the aftermath of World War II, the WJC undertook efforts to rebuild Jewish communities in Europe, provided assistance to displaced persons and Shoah survivors, pushed for the indemnification of victims by Germany, and advocated for the punishment of Nazi leaders who committed crimes against humanity.In 1951, WJC President Nahum Goldmann established the Conference of Jewish Material Claims Against Germany to handle Jewish reparation claims.The World Jewish Congress also successfully lobbied the United Nations and governments to support the establishment of the State of Israel. After 1948, the WJC focused its attention on the plight of Jewish refugees in Arab countries and also drew international attention to the plight of Jews in the Soviet Union, who were ultimately granted permission to move to Israel or to remain in their communities.During the 1980s, the World Jewish Congress exposed the Nazi past of former UN Secretary General Kurt Waldheim, who was elected president of Austria in 1986.During the 1990s, the WJC successfully lobbied for the restitution of assets of Holocaust victims held in so-called ‘dormant’ bank accounts in Switzerland and elsewhere, and it ensured that they were returned to their rightful owners, or that adequate compensation was paid. Commissions were set up in 17 nations to investigate Holocaust-era assets, including looted art, and the funds recovered have been used to support a multitude of programs worldwide.The WJC also fought for justice for forced laborers – both Jewish and non-Jewish – whose agonizing hardship had gone uncompensated for decades, resulting in the setting up of a US$ 5 billion fund by Germany in 2001.
The World Jewish Congress has also been at the forefront of fostering a better understanding with other religions, notably with the Catholic Church, and the organization facilitated the establishment of diplomatic relations between Israel and the Holy See in 1993. (photo: First Plenary Assembly)

Posted in Estero/world news, Spazio aperto/open space | Contrassegnato da tag: , , | Leave a Comment »